Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial
Annals of Oncology, 08/25/2011
De la Vega FA et al. – Erlotinib can be safely combined with chemoradiation without requiring dose reduction of chemo– or radiotherapy in this postsurgical population.






